AI-generated summary
The authors report a multicenter randomized trial of repeated low-level red-light therapy added to single vision spectacles in 202 children aged 7 to 12 with high myopia. After 12 months, the treatment group showed axial length shortening (-0.11 mm) while the control group lengthened (0.32 mm), and no fundus changes or visual acuity decline were reported. The study was single-blind, and the abstract reports only a single center's choroidal and retinal analysis.
- Participants
- 202
- Who or what was studied
- Children aged 7 to 12 years with high myopia (cycloplegia spherical equivalent of -6.00 diopters or worse)
- Limits stated in the abstract
- The trial was single-blind, and the abstract reports choroidal and retinal thickness data from only a single center.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Repeated low-level red light, Myopia, Randomized controlled trial, Control group, Primary outcome. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.